<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> infantile neurologic, cutaneous, articular (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CINCA</z:e>) syndrome is a severe <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e> that recently was associated with mutations in CIAS1 </plain></SENT>
<SENT sid="1" pm="."><plain>It was hypothesized that these mutations may lead to enhanced <z:mp ids='MP_0001845'>inflammatory responses</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Herein, we provide evidence that <z:mp ids='MP_0001845'>inflammation</z:mp> in the <z:e sem="disease" ids="C0409818" disease_type="Disease or Syndrome" abbrv="CINCA">CINCA syndrome</z:e> is characterized by enhanced interleukin-1beta (IL-1beta) and IL-18 release upon stimulation of blood cells and show that this release is caspase 1 dependent </plain></SENT>
</text></document>